txt_oben
bild_mitte

THURSDAY MAY 24, 2012:   CONTINUING EDUCATION
10.30 – 11.30
Embryogenesis of congenital eye disorders  (C. Cook)
11.30 – 12.00
Difference between hereditary and non-hereditary eye disease: some hints for the clinician (K. Narfström)
12.00 – 13.00
LUNCH
13.00 – 13.30
Developmental abnormalities in the eye and causative hereditary factors (G. Aguirre)
13.30 – 14.00
Cats have their own presumed hereditary eye diseases (K. Narfström)
13.30 – 14.00
Pigmentation and its relationship to hereditary eye disease (C. Cook)
14.00 – 14.45
How to deal with hereditary eye disease in ‘small’ dog or cat breed populations (G. Aguirre)
14.45 – 15.15
COFFEE BREAK
15.15 – 18.45
ECVO AGM (ECVO diplomates only)
19.00 
WELCOME RECEPTION (Savoia Excelsior Palace Hotel)

FRIDAY MAY 25, 2012
08.30 – 08.45
OPENING
08.45 – 10.00
RESIDENTS’ FORUM SESSION
10.00 – 10.30
COFFEE BREAK - POSTERS – INDUSTRIAL EXHIBITION
10.30 – 12.00
SCIENTIFIC SESSION
12.00 – 13.00
LUNCH - POSTERS – INDUSTRIAL EXHIBITION
13.00 – 14.00
POSTER SESSION & INDUSTRIAL EXHIBITION
14.00 – 15.00
SCIENTIFIC SESSION
15.00 – 15.30 
COFFEE BREAK - POSTERS – INDUSTRIAL EXHIBITION
15.30 – 17.00
EYE SCHEME UPDATES, HED SELF ASSESSMENT (K. Narfström, F. Stades)
17.30
Departure to POSTUMIA, visit to the CAVES and SOCIAL DINNER

SATURDAY MAY 26, 2012
08.30 – 10.00
SCIENTIFIC SESSION
10.00 – 10.30
COFFEE BREAK – POSTERS – INDUSTRIAL EXHIBITION
10.30 – 12.00
STATE OF THE ART LECTURE
Gene Therapy - from the Cage to the Bedside (G. Aguirre – A. Auricchio)
12.00 – 13.00
COFFEE BREAK – POSTERS – INDUSTRIAL EXHIBITION
13.00 – 14.00 
POSTER SESSION & INDUSTRIAL EXHIBITION
14.00 – 15.30
SCIENTIFIC SESSION
15.30 – 16.00 
COFFEE BREAK - POSTERS – INDUSTRIAL EXHIBITION
16.00 – 16.45
SCIENTIFIC SESSION
16.45 – 17.30
CLOSING AND AWARDS

SUNDAY MAY 27, 2012:  MASTERCLASS
08.30 – 09.30
Pigmentation and its relationship to congenital eye disease (C. Cook)
09.30 – 10.00
Molecular genetic testing possibilities – and are there any short-comings?  (G. Aguirre)
10.00 – 10.30
Advanced diagnostics for the clinician in regards to hereditary retinal disease (K. Narfström)
10.30-11.00 
COFFEE BREAK
11.00-11.40
Controversies in diagnostics of presumed hereditary eye disease (C. Cook)
11.40-12.30
Treatment options for presumed inherited eye disease(G. Aguirre)

   
Guest Speakers

ga

Gus Aguirre, VMD, PhD, PhDhc

Professor of Medical Genetics and Ophthalmology
School of Veterinary Medicine, University of Pennsylvania

Dr. Aguirre is a professor of medical genetics and ophthalmology at Penn Vet. He is a world-renowned researcher who, in 2001, led the research effort that restored vision to Lancelot, a dog who was born blind, through the use of gene therapy. Consequently, clinical trials in children were started for that type of blindness – Leber’s congenital amaurosis -- and so far have been showing efficacy and safety. After his success with treating Lancelot, Dr. Aguirre’s lab went on to study achromatopsia, and, with Dr. András Komaromy, assistant professor of ophthalmology at Penn Vet, serving as primary investigator, has also completed groundbreaking work in developing gene therapy to treat that type of blindness. Dr. Aguirre earned his VMD and PhD degrees from the University of Pennsylvania.
ck

Cynthia S. Cook, DVM, PhD

Dip. ACVO, Veterinary Vision
San Carlos, CA USA

Dr. Cynthia Cook received the Doctor of Veterinary Medicine degree from Iowa State University in 1980. She completed a residency in ophthalmology at North Carolina State University and became a board certified Diplomate of the American College of Veterinary Ophthalmologists in 1986. While in North Carolina, she also obtained a Ph.D. degree at UNC in medical cell biology and anatomy. In addition to her clinical interests, Dr. Cook serves as a research consultant to the pharmaceutical industry and universities. Dr. Cook has served as President of the American College of Veterinary Ophthalmologists, the San Francisco Veterinary Medical Association and the Peninsula Veterinary Medical Association. She also trains and competes with her terriers in agility.
kn

Kristina Narfström, DVM, PhD

Dipl. ECVO
Endowed Professor Emerita of Veterinary Ophthalmology

Kristina Narfström, DVM, PhD, and Diplomate of the European College of Veterinary Ophthalmology (ECVO), is the Ruth M. Kraeuchi Missouri Endowed Professor of Veterinary Ophthalmology. She holds adjunct professorships at the Mason Eye Institute, Department of Ophthalmology, and at the Faculty of Biomedical Engineering at the University of Missouri-Columbia. Her research work concerns primarily hereditary retinal disease processes of animal models, including retinal functional testing, using electroretinography. She is also engaged in comparative research concerning treatment modalities for hereditary retinal blinding diseases such as the use of gene therapy, stem cell implantation and retinal prosthetics. Narfström is cofounder and scientific director of RetVetCorp.
aa

Alberto Auricchio, MD

Associate Professor of Medical Genetics at the “Federico II” University
Full Investigator at the Telethon Institute of Genetics and Medicine

Alberto Auricchio, MD is Associate Professor of Medical Genetics at the “Federico II” University in Naples and Full Investigator at the Telethon Institute of Genetics and Medicine in Naples. Prof. Auricchio’s research is focused on gene therapy of retinal and metabolic diseases using adeno-associated viral vectors. Prof. Auricchio is co-author of more than 70 peer-reviewed publications on international scientific journals and inventor on several international patents on the use of viral vectors for gene therapy. Prof. Auricchio is a member of the Editorial boards of Human Gene Therapy and Molecular Therapy. Prof. Auricchio received the 2006 Outstanding New Investigator Award of the American Society of Gene Therapy, and has been nominated in 2007 “Cavaliere of the Italian Republic” by the President of the Italian Republic. In July 2011 Prof. Auricchio has been selected as recipient of a European Research Council Starting Grant.